INOZYME PHARMA, INC. Operating Cash Flow
INOZYME PHARMA, INC. reported Operating Cash Flow of -$29.15 million for the 3-month period ending 2025-03-31, per its 10-Q filed 2025-05-14.
Financial Statements › Cash Flow › Operating Activities
us-gaap:NetCashProvidedByUsedInOperatingActivities · last filed 2025-05-14
- INOZYME PHARMA, INC. net cash provided by (used in) operating activities for the quarter ending 2025-03-31 was -$29.15M.
- INOZYME PHARMA, INC. net cash provided by (used in) operating activities for the quarter ending 2024-12-31 was -$19.19M.
- INOZYME PHARMA, INC. net cash provided by (used in) operating activities for the quarter ending 2024-09-30 was -$24.53M.
- INOZYME PHARMA, INC. net cash provided by (used in) operating activities for the quarter ending 2024-06-30 was -$23.66M.
- INOZYME PHARMA, INC. net cash provided by (used in) operating activities for fiscal 2024 was -$91.91M.
- INOZYME PHARMA, INC. net cash provided by (used in) operating activities for fiscal 2023 was -$70.67M.
- INOZYME PHARMA, INC. net cash provided by (used in) operating activities for fiscal 2022 was -$57.76M.
- INOZYME PHARMA, INC. net cash provided by (used in) operating activities for fiscal 2021 was -$48.15M.
| Period end | Net Cash Provided by (Used in) Operating Activities 3 month | Net Cash Provided by (Used in) Operating Activities 6 month | Net Cash Provided by (Used in) Operating Activities 9 month | Net Cash Provided by (Used in) Operating Activities 12 month |
|---|---|---|---|---|
| 2025-03-31 | -$29.15M 10-Q · filed 2025-05-14 | -$48.34M derived: sum of 2 quarters · filed 2025-05-14 | -$72.86M derived: sum of 3 quarters · filed 2025-05-14 | -$96.52M derived: sum of 4 quarters · filed 2025-05-14 |
| 2024-12-31 | -$19.19M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-10 | -$43.72M derived: sum of 2 quarters · filed 2025-03-10 | -$67.37M derived: sum of 3 quarters · filed 2025-03-10 | -$91.91M 10-K · filed 2025-03-10 |
| 2024-09-30 | -$24.53M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-05 | -$48.19M derived: sum of 2 quarters · filed 2024-11-05 | -$72.72M 10-Q · filed 2024-11-05 | -$91.21M derived: sum of 4 quarters · filed 2025-05-14 |
| 2024-06-30 | -$23.66M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-06 | -$48.19M 10-Q · filed 2024-08-06 | -$66.68M derived: sum of 3 quarters · filed 2025-05-14 | -$85.55M derived: sum of 4 quarters · filed 2025-05-14 |
| 2024-03-31 | -$24.53M 10-Q · filed 2025-05-14 | -$43.02M derived: sum of 2 quarters · filed 2025-05-14 | -$61.89M derived: sum of 3 quarters · filed 2025-05-14 | -$77.44M derived: sum of 4 quarters · filed 2025-05-14 |
| 2023-12-31 | -$18.49M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-10 | -$37.35M derived: sum of 2 quarters · filed 2025-03-10 | -$52.90M derived: sum of 3 quarters · filed 2025-03-10 | -$70.67M 10-K · filed 2025-03-10 |
| 2023-09-30 | -$18.87M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-05 | -$34.42M derived: sum of 2 quarters · filed 2024-11-05 | -$52.19M 10-Q · filed 2024-11-05 | -$66.59M derived: sum of 4 quarters · filed 2024-11-05 |
| 2023-06-30 | -$15.55M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-06 | -$33.32M 10-Q · filed 2024-08-06 | -$47.72M derived: sum of 3 quarters · filed 2024-08-06 | -$62.23M derived: sum of 4 quarters · filed 2024-08-06 |
| 2023-03-31 | -$17.77M 10-Q · filed 2024-05-07 | -$32.17M derived: sum of 2 quarters · filed 2024-05-07 | -$46.69M derived: sum of 3 quarters · filed 2024-05-07 | -$61.37M derived: sum of 4 quarters · filed 2024-05-07 |
| 2022-12-31 | -$14.40M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-12 | -$28.91M derived: sum of 2 quarters · filed 2024-03-12 | -$43.60M derived: sum of 3 quarters · filed 2024-03-12 | -$57.76M 10-K · filed 2024-03-12 |
| 2022-09-30 | -$14.51M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-07 | -$29.20M derived: sum of 2 quarters · filed 2023-11-07 | -$43.36M 10-Q · filed 2023-11-07 | -$56.80M derived: sum of 4 quarters · filed 2023-11-07 |
| 2022-06-30 | -$14.69M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-08 | -$28.85M 10-Q · filed 2023-08-08 | -$42.29M derived: sum of 3 quarters · filed 2023-08-08 | -$54.59M derived: sum of 4 quarters · filed 2023-08-08 |
| 2022-03-31 | -$14.16M 10-Q · filed 2023-05-09 | -$27.60M derived: sum of 2 quarters · filed 2023-05-09 | -$39.90M derived: sum of 3 quarters · filed 2023-05-09 | -$49.94M derived: sum of 4 quarters · filed 2023-05-09 |
| 2021-12-31 | -$13.44M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-22 | -$25.74M derived: sum of 2 quarters · filed 2023-03-22 | -$35.78M derived: sum of 3 quarters · filed 2023-03-22 | -$48.15M 10-K · filed 2023-03-22 |
| 2021-09-30 | -$12.30M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-10 | -$22.33M derived: sum of 2 quarters · filed 2022-11-10 | -$34.71M 10-Q · filed 2022-11-10 | -$45.58M derived: sum of 4 quarters · filed 2022-11-10 |
| 2021-06-30 | -$10.03M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-15 | -$22.41M 10-Q · filed 2022-08-15 | -$33.28M derived: sum of 3 quarters · filed 2022-08-15 | -$43.48M derived: sum of 4 quarters · filed 2022-08-15 |
| 2021-03-31 | -$12.38M 10-Q · filed 2022-05-10 | -$23.25M derived: sum of 2 quarters · filed 2022-05-10 | -$33.45M derived: sum of 3 quarters · filed 2022-05-10 | -$42.09M derived: sum of 4 quarters · filed 2022-05-10 |
| 2020-12-31 | -$10.88M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-15 | -$21.08M derived: sum of 2 quarters · filed 2022-03-15 | -$29.71M derived: sum of 3 quarters · filed 2022-03-15 | -$35.97M 10-K · filed 2022-03-15 |
| 2020-09-30 | -$10.20M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-09 | -$18.83M derived: sum of 2 quarters · filed 2021-11-09 | -$25.10M 10-Q · filed 2021-11-09 | -$30.42M derived: sum of 4 quarters · filed 2021-11-09 |
| 2020-06-30 | -$8.63M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-11 | -$14.90M 10-Q · filed 2021-08-11 | -$20.22M derived: sum of 3 quarters · filed 2021-08-11 | -$23.54M derived: sum of 4 quarters · filed 2021-08-11 |
| 2020-03-31 | -$6.26M 10-Q · filed 2021-05-12 | -$11.59M derived: sum of 2 quarters · filed 2021-05-12 | -$14.90M derived: sum of 3 quarters · filed 2021-05-12 | |
| 2019-12-31 | -$5.32M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-25 | -$8.64M derived: sum of 2 quarters · filed 2021-03-25 | -$18.81M 10-K · filed 2021-03-25 | |
| 2019-09-30 | -$3.32M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-12 | -$13.49M 10-Q · filed 2020-11-12 | ||
| 2019-06-30 | -$10.17M 10-Q · filed 2020-09-03 |